Start

Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital

Frist:13 Feb 2025

Ausschreibungsinformationen

TED EU

Dublin, Ireland

Art
16
Verfahren
open
Referenznummer
10897-2025
Geschätzter Wert
22,000,000 EUR
CPV
33141530

The CA is tendering for the Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contra

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen